Risdiplam works by targeting the SMN2 gene to induce increased production of the survival motor neuron (SMN) protein; a deficiency of this protein is what causes the most common forms of SMA.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback